177 related articles for article (PubMed ID: 37733243)
1. An insight on medicinal attributes of 1,2,3- and 1,2,4-triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors.
Sharma A; Dubey R; Bhupal R; Patel P; Verma SK; Kaya S; Asati V
Mol Divers; 2023 Sep; ():. PubMed ID: 37733243
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and In Vitro α-Amylase and α-Glucosidase Dual Inhibitory Activities of 1,2,4-Triazole-Bearing
Khan I; Rehman W; Rahim F; Hussain R; Khan S; Rasheed L; Alanazi MM; Alanazi AS; Abdellattif MH
ACS Omega; 2023 Jun; 8(25):22508-22522. PubMed ID: 37396210
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Coumarin Derivatives as Potential Dual Inhibitors against α-Glucosidase and α-Amylase for the Management of Post-Prandial Hyperglycemia via Molecular Modelling Approaches.
Patil SM; Martiz RM; Satish AM; Shbeer AM; Ageel M; Al-Ghorbani M; Ranganatha L; Parameswaran S; Ramu R
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745030
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
Ritu ; Sharma P; Gupta GD; Asati V
Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
[TBL] [Abstract][Full Text] [Related]
5. α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline-1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation.
Cele N; Awolade P; Seboletswe P; Olofinsan K; Islam MS; Singh P
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015183
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
[TBL] [Abstract][Full Text] [Related]
7. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives.
Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids.
Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P
Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781
[TBL] [Abstract][Full Text] [Related]
9. New quinoline-based triazole hybrid analogs as effective inhibitors of α-amylase and α-glucosidase: Preparation,
Khan Y; Iqbal S; Shah M; Maalik A; Hussain R; Khan S; Khan I; Pashameah RA; Alzahrani E; Farouk AE; Alahmdi MI; Abd-Rabboh HSM
Front Chem; 2022; 10():995820. PubMed ID: 36186602
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
11. Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis,
Bukhari A; Nadeem H; Imran M; Muhammad SA
Iran J Basic Med Sci; 2021 Dec; 24(12):1632-1642. PubMed ID: 35432813
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by hydroxylated xanthones.
Santos CMM; Proença C; Freitas M; Araújo AN; Silva AMS; Fernandes E
Food Funct; 2022 Jul; 13(14):7930-7941. PubMed ID: 35788613
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities.
Khirallah SM; Ramadan HMM; Aladl HAA; Ayaz NO; Kurdi LAF; Jaremko M; Alshawwa SZ; Saied EM
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559028
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 2,6-di(substituted phenyl)thiazolo[3,2-b]-1,2,4-triazoles as α-glucosidase and α-amylase inhibitors, co-relative Pharmacokinetics and 3D QSAR and risk analysis.
Channar PA; Saeed A; Larik FA; Rashid S; Iqbal Q; Rozi M; Younis S; Mahar J
Biomed Pharmacother; 2017 Oct; 94():499-513. PubMed ID: 28780468
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
Molecules; 2023 May; 28(10):. PubMed ID: 37241920
[TBL] [Abstract][Full Text] [Related]
16. Quinazolinone-1,2,3-triazole-acetamide conjugates as potent α-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis, and molecular docking study.
Moghadam Farid S; Iraji A; Mojtabavi S; Ghasemi M; Faramarzi MA; Mahdavi M; Barazandeh Tehrani M; Akbarzadeh T; Saeedi M
RSC Med Chem; 2023 Mar; 14(3):520-533. PubMed ID: 36970140
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
[TBL] [Abstract][Full Text] [Related]
18. Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches.
Mahnashi MH; Alqahtani YS; Alqarni AO; Alyami BA; Jan MS; Ayaz M; Ullah F; Rashid U; Sadiq A
BMC Complement Med Ther; 2021 Oct; 21(1):270. PubMed ID: 34706708
[TBL] [Abstract][Full Text] [Related]
19. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
Kothari M; Kannan K; Sahadevan R; Sadhukhan S
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
[TBL] [Abstract][Full Text] [Related]
20. Identification of Cyclic Sulfonamides with an
Saddique FA; Ahmad M; Ashfaq UA; Muddassar M; Sultan S; Zaki MEA
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
